Read Online

The Evidence Base for the Classification of Drugs

by Ruth Levitt, Edward Nason, Michael Hallsworth

Download eBook for Free

Full Document

FormatFile SizeNotes
PDF file 0.6 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Summary Only

FormatFile SizeNotes
PDF file 0.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

This report, prepared for the UK House of Commons Select Committee on Science and Technology, presents the results of four case studies examining the evidence base for the classification of illegal drugs in the context of the Misuse of Drugs Act 1971. It identifies the main evidence on the selected drugs (amphetamines and ecstasy, cocaine, magic mushrooms and cannabis) and examines the use of that evidence in classifying each drug. The report also briefly examines the classification systems in three other countries (the USA, Sweden and the Netherlands), giving information on the penalties and treatment regimes associated with them.

The report provides a short introduction to the history of drug classification in the UK and general issues surrounding the types of evidence used in classifying drugs. The case studies examine the evidence of physical, social, psychological and economic harm associated with each drug and the use of that evidence by in government in making policy. This report does not aim to provide a comprehensive review of all the evidence available for the drugs or countries; rather it provides an overview of the evidence on drugs and classification systems, to assist the members of the committee to direct questions to witnesses in areas of specific interest to them for more in depth view information. The report may also be of wider interest to Parliament and others.

Table of Contents

  • Chapter One

    Introduction to drug classification

  • Chapter Two

    Amphetamines and ecstasy

  • Chapter Three

    Cocaine

  • Chapter Four

    Cannabis

  • Chapter Five

    Magic Mushrooms

  • Chapter Six

    International drug control legislation

Research conducted by

The research described in this report was prepared for the UK House of Commons Select Committee on Science and Technology and was conducted by RAND Europe.

This report is part of the RAND Corporation Technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.